Donald R. Young Purchases 20,000 Shares of Aspen Aerogels, Inc. (NYSE:ASPN) Stock

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) CEO Donald R. Young acquired 20,000 shares of Aspen Aerogels stock in a transaction that occurred on Monday, May 12th. The stock was bought at an average cost of $5.35 per share, with a total value of $107,000.00. Following the acquisition, the chief executive officer now directly owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Aspen Aerogels Stock Performance

ASPN traded up $0.69 during trading hours on Friday, reaching $6.38. The company's stock had a trading volume of 2,882,826 shares, compared to its average volume of 1,965,172. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $33.15. The company's 50-day moving average is $5.89 and its 200-day moving average is $10.07. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The firm has a market cap of $523.42 million, a PE ratio of 39.85 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The firm had revenue of $78.72 million for the quarter, compared to analysts' expectations of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The company's quarterly revenue was down 16.7% compared to the same quarter last year. During the same quarter last year, the business earned ($0.02) EPS. On average, equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Institutional Trading of Aspen Aerogels

Several large investors have recently bought and sold shares of the business. GAMMA Investing LLC boosted its stake in shares of Aspen Aerogels by 1,998.7% during the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock valued at $210,000 after purchasing an additional 3,158 shares in the last quarter. Banque Cantonale Vaudoise acquired a new stake in shares of Aspen Aerogels during the first quarter valued at about $45,000. Exchange Traded Concepts LLC boosted its stake in shares of Aspen Aerogels by 460.4% during the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after purchasing an additional 6,109 shares in the last quarter. Sandia Investment Management LP acquired a new stake in shares of Aspen Aerogels during the fourth quarter valued at about $89,000. Finally, CWM LLC boosted its stake in shares of Aspen Aerogels by 2,137.9% during the first quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after purchasing an additional 7,953 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ASPN shares. Craig Hallum dropped their target price on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a report on Friday, February 14th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Roth Mkm dropped their target price on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 14th. Finally, TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $19.11.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.